Phase ii proof‐of‐concept study of atorvastatin in castration‐resistant prostate cancer

HIGHLIGHTS

• who: PCSM and colleagues from the Institute of Cancer, College of Medical, Veterinary and Life and Cardiovascular and Medical, College of Medical, Veterinary and Life, University of Glasgow, CRUK Beatson Institute, Beatson have published the research work: Phase II proof‐of‐concept study of atorvastatin in castration‐resistant prostate cancer, in the Journal: (JOURNAL)
• what: If the study continued to the second stage, a further 23 evaluable patients would be recruited (total of 35), with the study aiming to recruit 40 patients in total. The primary study objective was to explore the impact of atorvastatin . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.